Board of Directors
In the News
Media Coverage: Old is not always gold, and other drug safety myths
Dr Danny Soon, CEO of CRIS and Executive Director of SCRI, debunks vaccine and other drug safety myths by going back to the roots of what matters in drug development and safety assessments.
Media Coverage: COVID-19 vaccine could become like yearly flu shot, say experts on Straits Times’ panel discussion
Dr Danny Soon, CEO of CRIS and Executive Director of SCRI, warned that the pandemic is far from over, as a small leak can take hold among unvaccinated people - but people now can do something about it and get vaccinated.
Media Coverage: New, unregistered vaccines offer choices to those allergic to mRNA Covid-19 vaccines
Allowing access to vaccines that are already in use elsewhere will give people in Singapore more options, said Dr Danny Soon, CEO of CRIS and Executive Director of SCRI.
Media Coverage: Straits Times Panel on Living with COVID-19: Singapore’s New Normal
Watch Dr Danny Soon (CEO of CRIS and Executive Director of SCRI) and other expert panellists in a discussion on how testing, tracing and vaccinations will feature in Singapore's post-pandemic life.
Media Coverage: COVID-19 Vaccines Boosted
Dr Danny Soon, CEO of CRIS and Executive Director of SCRI, discuss how ongoing research and developments have informed and allowed for timely and rational adjustments to Singapore's vaccine deployment policies.
Media Release: Singapore launches next phase of National Precision Medicine Programme
Singapore launches next phase of National Precision Medicine Programme New national body established to further research insights, improve patient outcomes and create new economic opportunities for the biomedical technology industry Established to coordinate a whole of government effort, Precision Health Research, Singapore (PRECISE) seeks to improve patient outcomes, implement data-driven healthcare and capture economic value […]
Media Release: Singapore Deep-Tech Alliance debuts venture builder to drive sustainability through Singapore’s Industry 4.0 Transformation
Singapore Deep-Tech Alliance partners create sustainable ventures from advanced technologies
Media Release: New personalised healthcare partnership formed to improve outcomes for people with cancer in Singapore
New personalised healthcare partnership formed to improve outcomes for people with cancer in Singapore Singapore Translational Cancer Consortium, National Cancer Centre Singapore, National University Hospital and Roche signed a Memorandum of Understanding (MOU) to leverage data insights and deepen understanding of unique drivers of disease to help improve health outcomes Public sector partners will provide […]
Media Coverage: Extraordinary 2020 Vaccines Speed
CRIS CEO, Dr Danny Soon, articulates why the vaccine development effort for Covid-19 has been like no other.
Media Coverage: Precision medicine key to preventing disease
Precision Health Research, Singapore (PRECISE) was incorporated to coordinate a whole-of-government effort to implement Phase II of Singapore’s 10-year precision medicine strategy.
Media Coverage: Committee for Singapore’s Covid-19 vaccination strategy
The Ministry of Health (MOH) has appointed a 14-member Expert Committee on COVID-19 Vaccination to make recommendations to the government on Singapore’s COVID-19 vaccination strategy.
Media Coverage: Paediatric Acute Respiratory Distress Syndrome (PARDS)
SCRI was featured in today’s Lianhe Zaobao on Paediatric Acute Respiratory Distress Syndrome (PARDS).
[ANNOUNCEMENT] Appointment of CEO (CRIS) and ED (SCRI)
About the Consortium for Clinical Research and Innovation Singapore (CRIS) The Consortium for Clinical Research and Innovation Singapore (CRIS), a wholly owned subsidiary of MOH Holdings, has been established in 2020 with the goal of strengthening synergies and promulgating strategies for national-level clinical research and translation programmes that are under the stewardship of the Ministry […]